[Federal Register Volume 73, Number 4 (Monday, January 7, 2008)]
[Notices]
[Page 1226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-25521]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse Draft Strategic Plan

AGENCY: National Institute on Drug Abuse, NIH, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institute on Drug Abuse (NIDA) is developing a 
strategic plan for the next 5 years, and invites the public to provide 
comments on a draft of this plan. The draft plan will be publicly 
available through the NIDA Draft Strategic Plan Web page (http://www.drugabuse.gov/StrategicPlan/Index.html) for 30 days from the 
publication of this Notice. The public is invited to provide comments 
via the e-mail address or the postal address listed on the NIDA Draft 
Strategic Plan Web page.
    Background: NIDA is the lead Federal agency for research on drug 
abuse and addiction. For the past three decades, NIDA has led the way 
in supporting research to prevent and treat drug abuse and addiction 
and mitigate the impact of their consequences--particularly the spread 
of HIV/AIDS and other infectious diseases. Given recent revolutionary 
advances in drug abuse research, NIDA has recently undergone a 
strategic planning process gathering recommendations from the National 
Advisory Council on Drug Abuse and from ongoing dialogue with our 
various stakeholder groups to establish achievable goals and objectives 
for the future.
    NIDA's draft Strategic Plan outlines four major goal areas--
Prevention, Treatment, HIV/AIDS, and Cross Cutting Priorities--each 
with Strategic Objectives that will guide NIDA's research agenda for 
the future. The public is invited to review this draft plan and provide 
comments. The draft plan may be viewed at http://www.drugabuse.gov/StrategicPlan/Index.html, and hard copies are available by calling 301-
443-1124 or by sending a letter requesting a copy (that includes your 
mailing address) to: National Institute on Drug Abuse, Attn: Draft 
Strategic Plan, 6001 Executive Blvd., Suite 5213, MSC 9561, Bethesda, 
MD 20892-9561.
    Request for Comments: The public is invited to provide comments on 
the draft Strategic Plan. Comments may be sent to the email address 
listed on the NIDA Strategic Planning Web page at http://www.drugabuse.gov/StrategicPlan/Index.html, or to the postal address 
listed above.
    Comments Due Date: Comments regarding NIDA's draft Strategic Plan 
should be submitted via e-mail to [email protected] no later than 
30 days after the publication of this Notice. Comments mailed to the 
above postal address must be postmarked by the same date.

    Dated: December 21, 2007.
Nora D. Volkow,
Director, National Institute on Drug Abuse, National Institutes of 
Health.
[FR Doc. E7-25521 Filed 1-4-08; 11:28 am]
BILLING CODE 4140-01-P